Ramm Pharma Corp Stock Current Valuation
| RAMMFDelisted Stock | USD 0.06 0.00 0.00% |
Valuation analysis of RAMM Pharma Corp helps investors to measure RAMM Pharma's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that RAMM Pharma's price fluctuation is very steady at this time. Calculation of the real value of RAMM Pharma Corp is based on 3 months time horizon. Increasing RAMM Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the RAMM pink sheet is determined by what a typical buyer is willing to pay for full or partial control of RAMM Pharma Corp. Since RAMM Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of RAMM Pink Sheet. However, RAMM Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.055 | Real 0.0468 | Hype 0.055 | Naive 0.055 |
The real value of RAMM Pink Sheet, also known as its intrinsic value, is the underlying worth of RAMM Pharma Corp Company, which is reflected in its stock price. It is based on RAMM Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of RAMM Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of RAMM Pharma Corp helps investors to forecast how RAMM pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of RAMM Pharma more accurately as focusing exclusively on RAMM Pharma's fundamentals will not take into account other important factors: RAMM Pharma Corp Company Current Valuation Analysis
RAMM Pharma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current RAMM Pharma Current Valuation | 1.85 M |
Most of RAMM Pharma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RAMM Pharma Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, RAMM Pharma Corp has a Current Valuation of 1.85 M. This is 99.99% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 99.99% higher than that of the company.
RAMM Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RAMM Pharma's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of RAMM Pharma could also be used in its relative valuation, which is a method of valuing RAMM Pharma by comparing valuation metrics of similar companies.RAMM Pharma is currently under evaluation in current valuation category among its peers.
RAMM Fundamentals
| Return On Equity | -0.12 | |||
| Return On Asset | -0.0789 | |||
| Profit Margin | (1.76) % | |||
| Operating Margin | (1.89) % | |||
| Current Valuation | 1.85 M | |||
| Shares Outstanding | 122.4 M | |||
| Shares Owned By Insiders | 34.88 % | |||
| Shares Owned By Institutions | 0.89 % | |||
| Price To Book | 0.18 X | |||
| Price To Sales | 4.04 X | |||
| Revenue | 4.12 M | |||
| Gross Profit | (37.32 K) | |||
| EBITDA | (6.36 M) | |||
| Net Income | (7.11 M) | |||
| Cash And Equivalents | 12.79 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 8.69 K | |||
| Current Ratio | 9.18 X | |||
| Book Value Per Share | 0.41 X | |||
| Cash Flow From Operations | (3.82 M) | |||
| Earnings Per Share | (0.05) X | |||
| Beta | -0.75 | |||
| Market Capitalization | 15.16 M | |||
| Total Asset | 59.71 M | |||
| Net Asset | 59.71 M |
About RAMM Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RAMM Pharma Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RAMM Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RAMM Pharma Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in RAMM Pink Sheet
If you are still planning to invest in RAMM Pharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RAMM Pharma's history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |